Department of Cardiology, Heze Municipal Hospital, Heze, China.
Eur Rev Med Pharmacol Sci. 2019 Jan;23(3 Suppl):153-160. doi: 10.26355/eurrev_201901_18642.
To explore the molecular mechanism of the cardioprotective effect of erythropoietin (EPO) in the rats with acute myocardial infarction (AMI) via the c-Jun N-terminal kinase (JNK) pathway.
The rat AMI models were constructed and randomly divided into the EPO group, AMI group, and Sham group. At 2 weeks after successful modeling, the cardiac function-related indicators of rats were determined, and after the rats were sacrificed, the left ventricular weight (LVW) index was measured. The enzyme-linked immunosorbent assay (ELISA) and the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay were employed to determine the levels of the related serum inflammatory factors and myocardial apoptosis, respectively. The apoptosis and the expression levels of the JNK pathway-related messenger ribonucleic acids (mRNA) and proteins in the myocardial tissues of all groups of rats were determined via Real Time-Polymerase Chain Reaction (RT-PCR) and immunohistochemistry.
After intervention with EPO, the EPO group had a substantially lower left ventricular end-diastolic pressure, but a remarkably higher left ventricular systolic pressure than the AMI group (p<0.05), and the LVW and LVW/body weight (BW) notably declined in the EPO group compared with those in AMI group (p<0.05). According to the ELISA results, the inflammatory factors were substantially raised in the AMI group compared with those in the other two groups (p<0.05) and significantly lowered after treatment with EPO (p<0.05). The TUNEL assay results revealed that EPO treatment could reverse the pathological changes in AMI to decrease the apoptosis to a large extent. It was detected via RT-PCR and immunohistochemistry that, compared with those in the Sham group, the expression level of the anti-apoptosis gene B-cell lymphoma 2 (Bcl-2) was substantially decreased, but the expression levels of pro-apoptosis gene Bcl-2 associated X protein (Bax) and the JNK pathway-related JNK and c-Jun were evidently elevated in the AMI group (p<0.05). Moreover, the expression level of Bcl-2 was remarkably raised (p<0.05) and the expression levels of Bax, JNK, and c-Jun remarkably declined (p<0.05) in the EPO group after intervention with EPO.
EPO can inhibit the inflammatory responses and decrease the myocardial apoptosis to protect the heart of the AMI rats, and its mechanism of action is related to the inhibition of the expression of the JNK pathway.
通过 c-Jun N-末端激酶(JNK)通路探索促红细胞生成素(EPO)对急性心肌梗死(AMI)大鼠的心脏保护作用的分子机制。
构建大鼠 AMI 模型,并将其随机分为 EPO 组、AMI 组和假手术组。在成功建模 2 周后,测定大鼠心功能相关指标,处死大鼠后测量左心室重量(LVW)指数。采用酶联免疫吸附测定(ELISA)和末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)检测法分别测定各组大鼠相关血清炎症因子和心肌细胞凋亡水平。采用实时聚合酶链反应(RT-PCR)和免疫组织化学法测定各组大鼠心肌组织中 JNK 通路相关信使 RNA(mRNA)和蛋白的凋亡和表达水平。
EPO 干预后,EPO 组大鼠左心室舒张末期压力明显降低,但左心室收缩压明显高于 AMI 组(p<0.05),EPO 组大鼠 LVW 和 LVW/体重(BW)明显低于 AMI 组(p<0.05)。ELISA 结果显示,AMI 组大鼠炎症因子明显高于其他两组(p<0.05),EPO 治疗后明显降低(p<0.05)。TUNEL 检测结果显示,EPO 治疗可逆转 AMI 的病理变化,在很大程度上减少细胞凋亡。RT-PCR 和免疫组织化学检测结果显示,与 Sham 组相比,AMI 组抗凋亡基因 B 细胞淋巴瘤 2(Bcl-2)表达水平明显降低,促凋亡基因 Bcl-2 相关 X 蛋白(Bax)和 JNK 通路相关 JNK 和 c-Jun 表达水平明显升高(p<0.05)。EPO 干预后,EPO 组 Bcl-2 表达水平明显升高(p<0.05),Bax、JNK 和 c-Jun 表达水平明显降低(p<0.05)。
EPO 可抑制炎症反应,减少心肌细胞凋亡,保护 AMI 大鼠心脏,其作用机制与抑制 JNK 通路表达有关。